AHP Redux litigation
Payments totaling $4.1 bil. were made in the first quarter, bringing American Home Product's total diet drug-related settlement pay-outs to approximately $8.2 bil. Since January, AHP has settled roughly 2,000 additional cases of the 10,000 remaining from claimants that opted out of the class action lawsuit. The company expects to make a total of $12.25 bil. in Redux-related payments (1"The Pink Sheet" Jan. 29, p. 18). AHP is in a net debt position of $3.4 bil. as of March 31
You may also be interested in...
American Home Products' latest cost estimate for the Redux liability case is approximately 25% higher than the cash payment AHP made in 1994 to acquire American Cyanamid.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials